cp wire

CP Wire Articles

UCB Receives Positive CHMP Opinion for Cimzia in Moderate-to-Severe Plaque Psoriasis

UCB announced on 4/27/18 that the European Committee for Medicinal Products for Human Use (CHMP) has recommended approval of a label extension for Cimzia (certolizumab pegol), to include a new... read more

Fri, 04/27/18 - 07:10 pm
Eloxx Receives Another Orphan-Drug Designation for ELX-02

Eloxx Pharmaceuticals, Inc. (“Eloxx”),  (NASDAQ:ELOX), announced on 4/27/18 that it has received orphan-drug designation from the Food and Drug Administration (FDA) for ELX-02 for treatment of... read more

Fri, 04/27/18 - 03:29 pm
Gilead Receives Positive Opinion From CHMP on Combination HIV Drug Biktarvy

Gilead Sciences, Inc. (NASDAQ:GILD) today announced on 4/27/18 the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA), has... read more

Fri, 04/27/18 - 09:55 am
Proniras Corporation Awarded Contract Worth up to $89.5 Million from BARDA to Develop Nerve Agent Countermeasure

Proniras Corporation, an Accelerator Life Science Partners portfolio company, announced on 4/27/18 that it has been awarded a contract potentially worth $89.5 million from the U.S. Department of... read more

Fri, 04/27/18 - 09:45 am
ImmunoGen Gets Good News From Interim Analysis of Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer
  • Interim futility analysis supports trial coninuation
  • Mirvetuximab soravtansine is the first FRa-targeting ADC


ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the... read more

Thu, 04/26/18 - 07:56 pm

Pages